Patents Assigned to Pluristerm Ltd.
  • Patent number: 9175262
    Abstract: Methods for treating conditions by administration of placenta derived adherent stromal cells to a subject in thereof are provided. Such conditions include skeletal muscle defects, neuropathic pain, and myocardial infarction. Also provided are methods wherein the adherent stromal cells administered are cultured under 2 dimensional or 3 dimensional growth conditions. Also provided are methods in which the cells administered are at least 70% adherent cells from a maternal or fetal portion of the placenta.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: November 3, 2015
    Assignee: Pluristerm Ltd.
    Inventor: Zami Aberman